UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033708
Receipt number R000038432
Scientific Title A verification study of improving on allergy-like symptoms to impacts on daily life with consumption of the test food containing fermented black jabara (Citrus jabara) in healthy Japanese subjects: a randomized, double-blind, placebo-controlled, parallel-group trial
Date of disclosure of the study information 2018/08/10
Last modified on 2019/08/16 09:09:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A verification study of improving on allergy-like symptoms to impacts on daily life with consumption of the test food containing fermented black jabara (Citrus jabara) in healthy Japanese subjects: a randomized, double-blind, placebo-controlled, parallel-group trial

Acronym

A verification study of improving on allergy-like symptoms to impacts on daily life with consumption of the test food containing fermented black jabara (Citrus jabara)

Scientific Title

A verification study of improving on allergy-like symptoms to impacts on daily life with consumption of the test food containing fermented black jabara (Citrus jabara) in healthy Japanese subjects: a randomized, double-blind, placebo-controlled, parallel-group trial

Scientific Title:Acronym

A verification study of improving on allergy-like symptoms to impacts on daily life with consumption of the test food containing fermented black jabara (Citrus jabara)

Region

Japan


Condition

Condition

Healthy Japanese subjects

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the effects of consumption of the test food containing fermented black jabara (Citrus jabara) for 4 weeks on allergy-like symptoms to impacts on daily life in healthy Japanese subjects with discomfort in their eyes and nose.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Japanese rhino-conjunctivitis quality of life questionnaire (JRQLQ No1)

* Assess the items at screening (before consumption) and 4 weeks after consumption.

Key secondary outcomes

1. Questionnaire based on practical guideline for the management of allergic rhinitis in Japan (record in the diary report)
sneezing, runny nose, blocked nose, itchy eyes, and watery eyes

2. Specific IgE (Dermatophagoides pteronyssinus, animal dander, Japanese red-cedar, orchard grass, timothy grass, ragweed, and moth)

3. Eosinophils in the nasal discharge

*1 Record the daily report every day from 1 week before starting consumption.
*2, 3 Assess the items at screening (before consumption) and 4 weeks after consumption.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Duration: 4 weeks
Test Material: Active capsule
Dosage: Take 3 capsules any time during the day with water or warm water

* If you forget to take the capsules, take capsules as soon as you remember within the day.

Interventions/Control_2

Duration: 4 weeks
Test Material: Placebo capsule
Dosage: Take 3 capsules any time during the day with water or warm water

* If you forget to take the capsules, take capsules as soon as you remember within the day.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Healthy Japanese adult subjects

2. Subjects who are experiencing discomfort in their eyes and nose

3. Subjects who are judged as eligible to participate in the study by the physician

4. Within the subjects who met the 1st to 3rd inclusion criteria, subjects whose total QOL score of JRQLQ No1 is relatively high at screening (before consumption)

Key exclusion criteria

1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction

2. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases

3. Subjects who are diagnosed with pollen allergy

4. Subjects who are diagnosed with allergic rhinitis

5. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily

6. Subjects who are currently taking medications (including herbal medicines) and supplements

7. Subjects who could have an allergy to raw materials of the test food, or possible to have serious allergic reactions to other foods and/or medicines

8. Subjects who are pregnant, lactation, or planning to become pregnant

9. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial

10. Subjects who are judged as ineligible to participate in the study by the physician

Target sample size

16


Research contact person

Name of lead principal investigator

1st name Kazuo
Middle name
Last name YAMAMOTO

Organization

ORTHOMEDICO Inc.

Division name

CEO

Zip code

112-0002

Address

2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.

TEL

03-3818-0610

Email

kazu@orthomedico.jp


Public contact

Name of contact person

1st name Naoko
Middle name
Last name SUZUKI

Organization

ORTHOMEDICO Inc.

Division name

R&D Department

Zip code

112-0002

Address

2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.

TEL

03-3818-0610

Homepage URL


Email

nao@orthomedico.jp


Sponsor or person

Institute

ORTHOMEDICO Inc.

Institute

Department

Personal name



Funding Source

Organization

Nisshin Honey co.,ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Medical Corporation Seishinkai, Takara Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethical committee of the Takara Clinic, Medical Corporation Seishinkai

Address

9F Taisei Building, 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan

Tel

03-5793-3623

Email

info@takara-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団盛心会 タカラクリニック (東京都)
Medical Corporation Seishinkai, Takara Clinic (Tokyo, Japan)


Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

18

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 06 Day

Date of IRB

2018 Year 08 Month 06 Day

Anticipated trial start date

2018 Year 08 Month 20 Day

Last follow-up date

2018 Year 11 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 08 Month 10 Day

Last modified on

2019 Year 08 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038432


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name